Axcelis price target raised to $160 from $150 at BofA
PremiumThe FlyAxcelis price target raised to $160 from $150 at BofA
15d ago
Axcelis price target raised to $150 from $125 at BofA
PremiumThe Fly
Axcelis price target raised to $150 from $125 at BofA
17d ago
Axcelis Announces Preliminary Financial Results for Second Quarter 2024 Ahead of Investor Event
PremiumPress Releases
Axcelis Announces Preliminary Financial Results for Second Quarter 2024 Ahead of Investor Event
18d ago
Amgen upgraded, Peloton downgraded: Wall Street’s top analyst calls
PremiumThe FlyAmgen upgraded, Peloton downgraded: Wall Street’s top analyst calls
3M ago
Axcelis price target lowered to $155 from $165 at B. Riley
PremiumThe Fly
Axcelis price target lowered to $155 from $165 at B. Riley
3M ago
Axcelis price target lowered to $170 from $180 at Benchmark
PremiumThe Fly
Axcelis price target lowered to $170 from $180 at Benchmark
3M ago
Axcelis sees Q2 EPS $1.30, consensus $1.49
PremiumThe FlyAxcelis sees Q2 EPS $1.30, consensus $1.49
3M ago
Axcelis reports Q1 EPS $1.57, consensus $1.24
PremiumThe Fly
Axcelis reports Q1 EPS $1.57, consensus $1.24
3M ago
Is ACLS a Buy, Before Earnings?
PremiumPre-Earnings
Is ACLS a Buy, Before Earnings?
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100